Eurosurveillance

Scope & Guideline

Advancing global health through open access research.

Introduction

Explore the comprehensive scope of Eurosurveillance through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore Eurosurveillance in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN1025-496x
PublisherEUR CENTRE DIS PREVENTION & CONTROL
Support Open AccessYes
CountrySweden
TypeJournal
Convergefrom 2001 to 2024
AbbreviationEUROSURVEILLANCE / Eurosurveillance
Frequency50 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressTOMTEBODAVAGEN 11A, STOCKHOLM 171 83, SWEDEN

Aims and Scopes

Eurosurveillance focuses on the surveillance, prevention, and control of infectious diseases in Europe and beyond. The journal aims to disseminate timely and relevant information on emerging public health threats, vaccine effectiveness, and the epidemiological characteristics of various infectious diseases, emphasizing collaborative efforts across countries to enhance public health strategies.
  1. Infectious Disease Surveillance:
    The journal provides insights into the epidemiology of infectious diseases across Europe, focusing on trends, outbreaks, and emerging pathogens. It emphasizes the importance of surveillance systems in detecting and responding to public health threats.
  2. Vaccine Effectiveness and Immunization Strategies:
    Research published in Eurosurveillance often evaluates the effectiveness of vaccines against various infectious diseases, particularly in the context of the COVID-19 pandemic and other vaccine-preventable diseases. It discusses strategies for improving vaccination coverage and addressing vaccine hesitancy.
  3. Public Health Response and Policy Development:
    The journal publishes studies on the effectiveness of public health interventions, response strategies to outbreaks, and the impact of health policies on disease control. This includes qualitative research on the implementation of measures during health crises.
  4. Antimicrobial Resistance:
    Eurosurveillance addresses the growing concern of antimicrobial resistance through studies that monitor resistance patterns, assess the impact of antimicrobial use, and explore strategies for combating resistant infections.
  5. One Health Approach:
    The journal promotes a One Health perspective, highlighting the interconnectedness of human, animal, and environmental health. Research often includes zoonotic diseases and the role of wildlife in disease transmission.
Eurosurveillance has increasingly focused on several emerging themes that reflect the evolving landscape of public health challenges. These trends highlight the journal's commitment to addressing contemporary issues in infectious disease epidemiology and control.
  1. Emerging Infectious Diseases and Pathogen Surveillance:
    Recent publications emphasize the surveillance of emerging infectious diseases, including novel pathogens like mpox (formerly monkeypox) and variants of SARS-CoV-2, reflecting a heightened awareness of global health threats.
  2. Impact of Climate Change on Infectious Disease Patterns:
    Research is increasingly exploring the relationship between climate change and the emergence of infectious diseases, such as vector-borne diseases, highlighting the need for adaptive public health strategies.
  3. COVID-19 and Its Aftermath:
    The journal continues to focus heavily on COVID-19, including studies on vaccine effectiveness, long COVID, and the consequences of the pandemic on healthcare systems and infectious disease epidemiology.
  4. Digital Health and Technology in Surveillance:
    There is a growing interest in the use of digital health tools, including wastewater surveillance and mobile health applications, to enhance disease detection and public health responses.
  5. Mental Health Impacts of Infectious Disease Outbreaks:
    Emerging research addresses the psychological and social impacts of infectious diseases, particularly in the context of the COVID-19 pandemic, recognizing the importance of mental health in public health initiatives.

Declining or Waning

While Eurosurveillance continues to address a wide array of infectious diseases, certain themes appear to be declining in prominence based on recent publications. This may reflect shifts in public health priorities or improvements in disease control measures.
  1. Focus on Historical Infectious Diseases:
    There has been a noticeable decline in publications focusing on historical infectious diseases that were once endemic but are now largely controlled in Europe, such as measles and rubella, as public health measures have significantly reduced their incidence.
  2. Non-communicable Disease Surveillance:
    The journal's emphasis on non-communicable diseases and their surveillance has decreased, possibly due to a stronger focus on infectious disease threats, particularly in the wake of the COVID-19 pandemic.
  3. Localized Outbreak Studies:
    Research related to localized outbreaks of less common infectious diseases appears to be waning, as the journal increasingly prioritizes broader epidemiological trends and multi-country outbreak investigations.
  4. Pediatric Infectious Diseases:
    There is a declining trend in the volume of studies specifically addressing pediatric infectious diseases, possibly due to a shift in focus towards adult populations in the context of the COVID-19 pandemic.

Similar Journals

CLINICAL INFECTIOUS DISEASES

Connecting research and practice in infectious diseases.
Publisher: OXFORD UNIV PRESS INCISSN: 1058-4838Frequency: 24 issues/year

Clinical Infectious Diseases, published by Oxford University Press Inc, is a premier journal in the fields of infectious diseases and microbiology, distinguished by its esteemed Q1 ranking in both categories as of 2023. Since its inception, the journal has served as a vital platform for disseminating cutting-edge research and significant advancements in the diagnosis, treatment, and prevention of infectious diseases. With a broad scope encompassing clinical trials, epidemiological studies, and public health research, it targets a diverse readership, including researchers, healthcare professionals, and students. The journal's robust reputation is underscored by its impactful contributions to scientific understanding, making it a critical resource for those striving to combat infectious diseases globally. Clinical Infectious Diseases is not open access but offers various subscription options, ensuring comprehensive access to its high-quality content. With a historical continuity from 1985 to present, the journal remains at the forefront of medical research, paving the way for future innovations in the field.

Biosafety and Health

Fostering collaboration in biotechnology and microbiology.
Publisher: ELSEVIERISSN: 2096-6962Frequency: 6 issues/year

Biosafety and Health is a leading peer-reviewed journal published by ELSEVIER, dedicated to advancing knowledge and practice in the fields of biotechnology, infectious diseases, microbiology, and public health. With an ISSN of 2096-6962 and an E-ISSN of 2590-0536, this Open Access journal has been accessible to the global research community since 2019, fostering collaboration and innovation from its base in the Netherlands. Ranked Q2 in multiple categories according to the latest metrics, including Biotechnology and Microbiology (medical), it stands as a testament to high-quality, impactful research that influences clinical and environmental practices. The journal has achieved substantial recognition in various medical fields, ranking in the 88th percentile for Public Health, Environmental and Occupational Health, and the 78th percentile for Infectious Diseases. Researchers and practitioners seeking to contribute to this evolving domain are encouraged to submit their findings, as the journal aims to promote interdisciplinary dialogue and address pressing global health challenges.

New Microbes and New Infections

Pioneering research on emerging microbes and infections.
Publisher: ELSEVIER SCI LTDISSN: Frequency: 6 issues/year

New Microbes and New Infections is an esteemed peer-reviewed journal published by Elsevier Sci Ltd that has been a prominent platform for disseminating groundbreaking research in the fields of Infectious Diseases and Microbiology since its establishment in 2013. With an impressive Open Access model, this journal ensures that vital research findings are readily accessible to researchers, healthcare professionals, and academics worldwide. Positioned in the Q2 category for Infectious Diseases and Q3 for Microbiology in 2023, it reaches a significant global audience, as demonstrated by its high Scopus rankings—#44 out of 344 in Medicine: Infectious Diseases, and #34 out of 182 in Immunology and Microbiology. The journal aims to inspire new ideas and foster collaborations by publishing high-quality research focused on novel microbes and infections, thus playing a crucial role in advancing science and public health in an era where understanding infectious agents is more vital than ever.

JAPANESE JOURNAL OF INFECTIOUS DISEASES

Elevating standards in infectious disease research since 1961.
Publisher: NATL INST INFECTIOUS DISEASESISSN: 1344-6304Frequency: 6 issues/year

The Japanese Journal of Infectious Diseases, published by the National Institute of Infectious Diseases in Japan, serves as a vital platform for researchers, clinicians, and public health professionals committed to advancing the field of infectious disease science. With an ISSN of 1344-6304 and an E-ISSN of 1884-2836, this journal has maintained its academic rigor since its inception in 1961 and continues to contribute significantly to the global understanding of infectious diseases. The journal holds a Q3 ranking in the categories of Infectious Diseases, Miscellaneous Medicine, and Medical Microbiology as of 2023, reflecting its important role in disseminating impactful research. With many articles available through Open Access, it ensures wide accessibility to the latest discoveries and insights. Researchers can expect to find high-quality studies that address critical challenges in the control and prevention of infectious diseases, making this journal an essential resource for anyone engaging in this critical field.

EMERGING INFECTIOUS DISEASES

Empowering Researchers to Tackle Emerging Diseases
Publisher: CENTERS DISEASE CONTROL & PREVENTIONISSN: 1080-6040Frequency: 12 issues/year

Emerging Infectious Diseases, published by the Centers for Disease Control and Prevention, is a leading open-access journal that has been dedicated to the field of epidemiology, infectious diseases, and medical microbiology since its inception in 1995. With an impressive impact factor placing it in the Q1 quartile rankings for multiple categories including Epidemiology, Infectious Diseases, and Medical Microbiology, this journal serves as a vital resource for researchers, practitioners, and students dedicated to combating the challenges posed by emerging infectious diseases. The journal's distinguished Scopus ranks further highlight its global influence, ranking #10 in Epidemiology, #26 in Infectious Diseases, and #13 in Medical Microbiology, all within the top percentiles. Accessible and targeted, Emerging Infectious Diseases publishes seminal research and reviews that contribute to the understanding and management of infectious diseases, ensuring that critical insights reach a broad audience. The journal encourages contributions that advance the scientific community’s knowledge and responses to public health challenges.

Archives of Clinical Infectious Diseases

Empowering Professionals with Cutting-Edge Research
Publisher: BRIEFLANDISSN: 2345-2641Frequency: 4 issues/year

Archives of Clinical Infectious Diseases is a peer-reviewed journal dedicated to advancing knowledge in the field of infectious diseases, published by BRIEFLAND in Iran. With a broad scope, it covers various aspects of cardiology, critical care, immunology, microbiology, public health, and toxicology, affirming its relevance in today's health landscape. Despite the lack of open access options, the journal maintains a strong reputation, reflected in its Q3 ranking in multiple categories within the 2023 category quartiles. The journal aims to provide a platform for researchers and practitioners to disseminate critical findings that can impact clinical practices and public health policies. Its commitment to rigorous peer review ensures that only high-quality research is published, thereby serving as an essential resource for professionals, students, and public health advocates. For those engaged in the ever-evolving world of infectious diseases, Archives of Clinical Infectious Diseases stands as a vital contribution to the medical literature.

Infektsiya i Immunitet

Illuminating the path in immunology and infection studies.
Publisher: SANKT-PETERSBURG-NIIEM IMENI PASTERAISSN: 2220-7619Frequency: 4 issues/year

Infektsiya i Immunitet, published by the esteemed SANKT-PETERSBURG-NIIEM IMENI PASTERA, is a prominent open access journal that has been disseminating vital research findings since 2011. Focusing on the fields of immunology and infectious diseases, this journal serves as a critical platform for scholars, professionals, and students in the Russian Federation and beyond. With an ISSN of 2220-7619 and an E-ISSN of 2313-7398, it currently holds a Q4 ranking in 2023 for both Immunology and Infectious Diseases, along with notable quartile standings in related fields. Despite its emerging status, Infektsiya i Immunitet provides valuable insights and contributes to the growing discourse on immunity and infection prevention strategies, making it an essential resource for those invested in advancing knowledge and enhancing public health outcomes. Researchers can conveniently access its wealth of articles and studies that bridge theoretical understanding and practical implications in their respective domains.

Reviews and Research in Medical Microbiology

Catalyzing Change in the Study of Infectious Diseases
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 2770-3150Frequency: 4 issues/year

Reviews and Research in Medical Microbiology is a premier academic journal published by LIPPINCOTT WILLIAMS & WILKINS, focusing on groundbreaking research and comprehensive reviews that advance the understanding of medical microbiology. With an ISSN of 2770-3150 and an E-ISSN of 2770-3169, this journal serves as an essential resource for researchers, healthcare professionals, and students dedicated to the study of pathogens, infectious diseases, and microbial mechanisms affecting health. While the journal currently does not offer open access, its rigorous peer-review process ensures that only high-quality, impactful research is disseminated to the scientific community. The journal aims to bridge gaps in knowledge by presenting cutting-edge studies that explore novel therapeutic strategies, diagnostic methods, and the evolving landscape of microbial resistance. Nestled in the heart of Philadelphia, this journal proudly contributes to the advancement of medical microbiology and is an indispensable platform for the publication of critical findings that shape clinical practices and research trajectories in the field.

Infectious Diseases and Clinical Microbiology

Bridging research and clinical practice in infectious health.
Publisher: DOC DESIGN INFORMATICS CO LTDISSN: 2667-646XFrequency: 4 issues/year

Infectious Diseases and Clinical Microbiology is a pivotal journal dedicated to advancing our understanding of infectious diseases through rigorous scientific research and clinical practices. Published by DOC DESIGN INFORMATICS CO LTD, this journal serves as a vital platform for researchers, healthcare professionals, and students keen on enhancing their knowledge of microbiological sciences and the clinical implications of infectious agents. With an ISSN of 2667-646X, it aims to disseminate significant findings in the field, enriching the scholarly dialogue surrounding infectious diseases. While currently operating under a traditional access model, the journal encourages global collaboration and knowledge sharing, striving to make a meaningful impact in tackling the challenges posed by infectious diseases. Its content aims to bridge the gap between laboratory research and clinical application, making it an essential resource in the contemporary landscape of global health.

Tropical Medicine and Infectious Disease

Empowering knowledge in tropical medicine and public health.
Publisher: MDPIISSN: Frequency: 12 issues/year

Tropical Medicine and Infectious Disease, published by MDPI, is a leading peer-reviewed journal dedicated to advancing the field of tropical medicine and infectious diseases. With an open access model established since 2016, this journal fosters a collaborative environment for researchers, professionals, and students from around the world to disseminate cutting-edge findings and innovative approaches to public health challenges, particularly in tropical regions. The journal has earned recognition, achieving a Q2 quartile ranking in notable fields including Immunology and Microbiology, Infectious Diseases, and Public Health, Environmental, and Occupational Health in 2023, indicative of its influence and relevance in the scientific community. With a focus on high-quality research, Tropical Medicine and Infectious Disease aims to bridge the gap between basic science and clinical application, providing invaluable insights critical for combating infectious diseases and improving health outcomes in vulnerable populations. The journal’s accessibility and substantial indexing in major databases further solidify its importance as a key platform for impactful research in this essential field.